US EditionLung Immune Cell Type "Quietly" Controls Inflammation in COVID-19
- A new study shows that nerve and airway-associated interstitial macrophages are crucial for survival from COVID-19 by controlling lung inflammation during infection with SARS-CoV-2.
- Research led by NYU Langone Health found that mice lacking NAMs had heightened inflammation and failed to survive COVID-19 infection.
- Experiments demonstrated that mice lacking NAMs had worsened inflammation and increased viral spread, resulting in their deaths.
- Tests on lung tissue from intubated COVID-19 patients indicated decreased NAM activity in those who died, supporting the findings from mice studies.
Insights by Ground AI
Does this summary seem wrong?
30 Articles
30 Articles
All
Left
Center
10
Right
2
This Lung Cell Decides Who Survives COVID
Scientists have discovered that a rare immune cell type in the lungs, called NAMs, plays a crucial role in surviving COVID-19 by keeping the body's immune response from turning dangerously destructive. Rather than simply battling the virus, these cells act like peacekeepers, reining in excessive
COVID-19: These immune cells decide on life and death
According to a new study, a rare cell type in the lungs is crucial for survival after a COVID-19 infection.The article COVID-19: These immune cells decide on life and death first appeared on ingenieur.de - Jobbörse und Nachrichtenportal für Ingenieure.
·Düsseldorf, Germany
Read Full ArticleCoverage Details
Total News Sources30
Leaning Left0Leaning Right2Center10Last UpdatedBias Distribution83% Center
Bias Distribution
- 83% of the sources are Center
83% Center
C 83%
R 17%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
